like I said a couple of days agoSarepta fell to $115Pfizer phase...

like I said a couple of days ago
Sarepta fell to $115
Pfizer phase 3 trial did not meet its end points
Sareptas sp went up to $125

Today …still another 3and 1/2 hrs trading
and the sp is in free fall

That tells me FDA is going to reject Srp901 for the whole DMD population…

Whats it to Per
Heaps !
GT in the video said
Atl1102 in combination with all the Exon skipping drugs gives a boost
but Atl on its own is better.
and also better than corticosteroids

Atl1102 is an anti inflammatory drug which not only applies to rare diseases but almost every other disease

is PER going to be the next CSL?

IMO..
yes $$